Skip to main content
Log in

Frontal hypometabolism in the diagnosis of progressive supranuclear palsy clinical variants

  • Original Communication
  • Published:
Journal of Neurology Aims and scope Submit manuscript

Abstract

Objective

Frontal hypometabolism on FDG-PET is observed in progressive supranuclear palsy (PSP), although it is unclear whether it is a feature of all PSP clinical variants and hence whether it is a useful diagnostic feature. We aimed to compare the frequency, severity, and pattern of frontal hypometabolism across PSP variants and determine whether frontal hypometabolism is related to clinical dysfunction.

Methods

Frontal hypometabolism in prefrontal, premotor, and sensorimotor cortices was visually graded on a 0–3 scale using CortexID Z-score images in 137 PSP patients. Frontal asymmetry was recorded. Severity scores were used to categorize patients as premotor-predominant, prefrontal-predominant, sensorimotor-predominant, mixed-predominance, or no regional predominance. Frontal ratings were compared across PSP clinical variants, and Spearman correlations were used to assess relationships with the Frontal Assessment Battery (FAB).

Results

97% showed evidence of frontal hypometabolism which was most common (100%) in the speech–language (PSP-SL), corticobasal (PSP-CBS), and frontal (PSP-F) variants and least common in the progressive gait freezing (PSP-PGF) variant (73%). PSP-SL and PSP-CBS showed more severe hypometabolism than Richardson’s syndrome (PSP-RS), Parkinsonism (PSP-P), and PSP-PGF. A premotor-predominant pattern was most common in PSP-SL and PSP-CBS, with more mixed patterns in the other variants. Hypometabolism was most commonly asymmetric in PSP-SL, PSP-P, PSP-F and PSP-CBS. Worse hypometabolism in nearly all frontal regions correlated with worse scores on the FAB.

Conclusions

Frontal hypometabolism is a common finding in PSP, although it varies in severity and pattern across PSP variants and will likely be the most diagnostically useful in PSP-SL and PSP-CBS.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4

Similar content being viewed by others

Data availability

The data that support the findings of this study are available from the corresponding author upon reasonable request.

References

  1. Adachi M, Kawanami T, Ohshima H, Sugai Y, Hosoya T (2004) Morning glory sign: a particular MR finding in progressive supranuclear palsy. Magn Reson Med Sci 3:125–132

    Article  PubMed  Google Scholar 

  2. Armstrong MJ, Litvan I, Lang AE, Bak TH, Bhatia KP, Borroni B, Boxer AL, Dickson DW, Grossman M, Hallett M, Josephs KA, Kertesz A, Lee SE, Miller BL, Reich SG, Riley DE, Tolosa E, Troster AI, Vidailhet M, Weiner WJ (2013) Criteria for the diagnosis of corticobasal degeneration. Neurology 80:496–503

    Article  PubMed  PubMed Central  Google Scholar 

  3. Dubois B, Slachevsky A, Litvan I, Pillon B (2000) The FAB: a Frontal Assessment Battery at bedside. Neurology 55:1621–1626

    Article  CAS  PubMed  Google Scholar 

  4. Garraux G, Salmon E, Degueldre C, Lemaire C, Laureys S, Franck G (1999) Comparison of impaired subcortico-frontal metabolic networks in normal aging, subcortico-frontal dementia, and cortical frontal dementia. Neuroimage 10:149–162

    Article  CAS  PubMed  Google Scholar 

  5. Gerstenecker A, Mast B, Duff K, Ferman TJ, Litvan I, Group E-PS (2013) Executive dysfunction is the primary cognitive impairment in progressive supranuclear palsy. Arch Clin Neuropsychol 28:104–113

    Article  PubMed  Google Scholar 

  6. Goetz CG, Fahn S, Martinez-Martin P, Poewe W, Sampaio C, Stebbins GT, Stern MB, Tilley BC, Dodel R, Dubois B, Holloway R, Jankovic J, Kulisevsky J, Lang AE, Lees A, Leurgans S, LeWitt PA, Nyenhuis D, Olanow CW, Rascol O, Schrag A, Teresi JA, Van Hilten JJ, LaPelle N (2007) Movement Disorder Society-sponsored revision of the Unified Parkinson’s Disease Rating Scale (MDS-UPDRS): process, format, and clinimetric testing plan. Mov Disord 22:41–47

    Article  PubMed  Google Scholar 

  7. Golbe LI, Ohman-Strickland PA (2007) A clinical rating scale for progressive supranuclear palsy. Brain 130:1552–1565

    Article  PubMed  Google Scholar 

  8. Grijalva RM, Pham NTT, Huang Q, Martin PR, Ali F, Clark HM, Duffy JR, Utianski RL, Botha H, Machulda MM, Weigand SD, Ahlskog JE, Dickson DW, Josephs KA, Whitwell JL (2022) Brainstem biomarkers of clinical variant and pathology in progressive supranuclear palsy. Mov Disord 37:702–712

    Article  CAS  PubMed  Google Scholar 

  9. Grimm MJ, Respondek G, Stamelou M, Arzberger T, Ferguson L, Gelpi E, Giese A, Grossman M, Irwin DJ, Pantelyat A, Rajput A, Roeber S, van Swieten JC, Troakes C, Antonini A, Bhatia KP, Colosimo C, van Eimeren T, Kassubek J, Levin J, Meissner WG, Nilsson C, Oertel WH, Piot I, Poewe W, Wenning GK, Boxer A, Golbe LI, Josephs KA, Litvan I, Morris HR, Whitwell JL, Compta Y, Corvol JC, Lang AE, Rowe JB, Hoglinger GU, Movement Disorder Society-endorsed PSPSG (2019) How to apply the movement disorder society criteria for diagnosis of progressive supranuclear palsy. Mov Disord 34:1228–1232

    Article  PubMed  PubMed Central  Google Scholar 

  10. Grisoli M, Fetoni V, Savoiardo M, Girotti F, Bruzzone MG (1995) MRI in corticobasal degeneration. Eur J Neurol 2:547–552

    Article  CAS  PubMed  Google Scholar 

  11. Hass RM, Whitwell JL, Coon EA, Josephs KA, Ali F (2023) Mitochondrial encephalopathy with lactic-acidosis and stroke-like episodes syndrome presenting as progressive supranuclear palsy. Parkinsonism Relat Disord 113:105516

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  12. Hassan A, Parisi JE, Josephs KA (2012) Autopsy-proven progressive supranuclear palsy presenting as behavioral variant frontotemporal dementia. Neurocase 18:478–488

    Article  PubMed  Google Scholar 

  13. Hoglinger GU, Respondek G, Stamelou M, Kurz C, Josephs KA, Lang AE, Mollenhauer B, Muller U, Nilsson C, Whitwell JL, Arzberger T, Englund E, Gelpi E, Giese A, Irwin DJ, Meissner WG, Pantelyat A, Rajput A, van Swieten JC, Troakes C, Antonini A, Bhatia KP, Bordelon Y, Compta Y, Corvol JC, Colosimo C, Dickson DW, Dodel R, Ferguson L, Grossman M, Kassubek J, Krismer F, Levin J, Lorenzl S, Morris HR, Nestor P, Oertel WH, Poewe W, Rabinovici G, Rowe JB, Schellenberg GD, Seppi K, van Eimeren T, Wenning GK, Boxer AL, Golbe LI, Litvan I, Movement Disorder Society-endorsed PSPSG (2017) Clinical diagnosis of progressive supranuclear palsy: the movement disorder society criteria. Mov Disord 32:853–864

    Article  PubMed  PubMed Central  Google Scholar 

  14. Hurtado-Pomares M, Carmen Terol-Cantero M, Sanchez-Perez A, Peral-Gomez P, Valera-Gran D, Navarrete-Munoz EM (2018) The frontal assessment battery in clinical practice: a systematic review. Int J Geriatr Psychiatry 33:237–251

    Article  PubMed  Google Scholar 

  15. Jakabek D, Power BD, Macfarlane MD, Walterfang M, Velakoulis D, van Westen D, Latt J, Nilsson M, Looi JCL, Santillo AF (2018) Regional structural hypo- and hyperconnectivity of frontal-striatal and frontal-thalamic pathways in behavioral variant frontotemporal dementia. Hum Brain Mapp 39:4083–4093

    Article  PubMed  PubMed Central  Google Scholar 

  16. Josephs KA, Duffy JR, Strand EA, Machulda MM, Senjem ML, Gunter JL, Schwarz CG, Reid RI, Spychalla AJ, Lowe VJ (2014) The evolution of primary progressive apraxia of speech. Brain 137:2783–2795

    Article  PubMed  PubMed Central  Google Scholar 

  17. Josephs KA, Duffy JR, Strand EA, Machulda MM, Senjem ML, Lowe VJ, Jack CR, Whitwell JL (2013) Syndromes dominated by apraxia of speech show distinct characteristics from agrammatic PPA. Neurology 81:337–345

    Article  PubMed  PubMed Central  Google Scholar 

  18. Josephs KA, Duffy JR, Strand EA, Whitwell JL, Layton KF, Parisi JE, Hauser MF, Witte RJ, Boeve BF, Knopman DS, Dickson DW, Jack CR Jr, Petersen RC (2006) Clinicopathological and imaging correlates of progressive aphasia and apraxia of speech. Brain 129:1385–1398

    Article  PubMed  Google Scholar 

  19. Josephs KA, Eggers SD, Jack CR Jr, Whitwell JL (2012) Neuroanatomical correlates of the progressive supranuclear palsy corticobasal syndrome hybrid. Eur J Neurol 19:1440–1446

    Article  CAS  PubMed  Google Scholar 

  20. Josephs KA, Katsuse O, Beccano-Kelly DA, Lin WL, Uitti RJ, Fujino Y, Boeve BF, Hutton ML, Baker MC, Dickson DW (2006) Atypical progressive supranuclear palsy with corticospinal tract degeneration. J Neuropathol Exp Neurol 65:396–405

    Article  PubMed  Google Scholar 

  21. Kato N, Arai K, Hattori T (2003) Study of the rostral midbrain atrophy in progressive supranuclear palsy. J Neurol Sci 210:57–60

    Article  PubMed  Google Scholar 

  22. Kovacs GG, Lukic MJ, Irwin DJ, Arzberger T, Respondek G, Lee EB, Coughlin D, Giese A, Grossman M, Kurz C, McMillan CT, Gelpi E, Compta Y, van Swieten JC, Laat LD, Troakes C, Al-Sarraj S, Robinson JL, Roeber S, Xie SX, Lee VM, Trojanowski JQ, Hoglinger GU (2020) Distribution patterns of tau pathology in progressive supranuclear palsy. Acta Neuropathol 140:99–119

    Article  PubMed  PubMed Central  Google Scholar 

  23. Kurz C, Ebersbach G, Respondek G, Giese A, Arzberger T, Hoglinger GU (2016) An autopsy-confirmed case of progressive supranuclear palsy with predominant postural instability. Acta Neuropathol Commun 4:120

    Article  PubMed  PubMed Central  Google Scholar 

  24. Laureys S, Salmon E, Garraux G, Peigneux P, Lemaire C, Degueldre C, Franck G (1999) Fluorodopa uptake and glucose metabolism in early stages of corticobasal degeneration. J Neurol 246:1151–1158

    Article  CAS  PubMed  Google Scholar 

  25. Marconi R, Antonini A, Barone P, Colosimo C, Avarello TP, Bottacchi E, Cannas A, Ceravolo MG, Ceravolo R, Cicarelli G, Gaglio RM, Giglia L, Iemolo F, Manfredi M, Meco G, Nicoletti A, Pederzoli M, Petrone A, Pisani A, Pontieri FE, Quatrale R, Ramat S, Scala R, Volpe G, Zappulla S, Bentivoglio AR, Stocchi F, Trianni G, Del Dotto P, De Gaspari D, Grasso L, Morgante F, Santangelo G, Fabbrini G, Morgante L, group Ps, (2012) Frontal assessment battery scores and non-motor symptoms in parkinsonian disorders. Neurol Sci 33:585–593

    Article  PubMed  Google Scholar 

  26. Marti-Andres G, van Bommel L, Meles SK, Riverol M, Valenti R, Kogan RV, Renken RJ, Gurvits V, van Laar T, Pagani M, Prieto E, Luquin MR, Leenders KL, Arbizu J (2020) Multicenter validation of metabolic abnormalities related to PSP according to the MDS-PSP criteria. Mov Disord 35:2009–2018

    Article  CAS  PubMed  Google Scholar 

  27. Minoshima S, Frey KA, Koeppe RA, Foster NL, Kuhl DE (1995) A diagnostic approach in Alzheimer’s disease using three-dimensional stereotactic surface projections of fluorine-18-FDG PET. J Nucl Med 36:1238

    CAS  PubMed  Google Scholar 

  28. Nasreddine ZS, Phillips NA, Bedirian V, Charbonneau S, Whitehead V, Collin I, Cummings JL, Chertkow H (2005) The Montreal Cognitive Assessment, MoCA: a brief screening tool for mild cognitive impairment. J Am Geriatr Soc 53:695–699

    Article  PubMed  Google Scholar 

  29. Orlandi F, Carlos AF, Ali F, Clark HM, Duffy JR, Utianski RL, Botha H, Machulda MM, Yehkyoung CS, Schwarz CG, Senjem ML, Jack CR, Agosta F, Filippi M, Dickson DW, Josephs KA, Whitwell JL (2024) Histologic tau lesions and MRI biomarkers in PSP-Richardson syndrome and PSP-Speech-Language variant. Brain Commun (in press)

  30. Pardini M, Huey ED, Spina S, Kreisl WC, Morbelli S, Wassermann EM, Nobili F, Ghetti B, Grafman J (2019) FDG-PET patterns associated with underlying pathology in corticobasal syndrome. Neurology 92:e1121–e1135

    Article  PubMed  PubMed Central  Google Scholar 

  31. Park HK, Kim JS, Im KC, Oh SJ, Kim MJ, Lee JH, Chung SJ, Lee MC (2009) Functional brain imaging in pure akinesia with gait freezing: [18F] FDG PET and [18F] FP-CIT PET analyses. Mov Disord 24:237–245

    Article  PubMed  Google Scholar 

  32. Paviour DC, Winterburn D, Simmonds S, Burgess G, Wilkinson L, Fox NC, Lees AJ, Jahanshahi M (2005) Can the frontal assessment battery (FAB) differentiate bradykinetic rigid syndromes? Relation of the FAB to formal neuropsychological testing. Neurocase 11:274–282

    Article  CAS  PubMed  Google Scholar 

  33. Piattella MC, Tona F, Bologna M, Sbardella E, Formica A, Petsas N, Filippini N, Berardelli A, Pantano P (2015) Disrupted resting-state functional connectivity in progressive supranuclear palsy. AJNR Am J Neuroradiol 36:915–921

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  34. Respondek G, Stamelou M, Kurz C, Ferguson LW, Rajput A, Chiu WZ, van Swieten JC, Troakes C, Al Sarraj S, Gelpi E, Gaig C, Tolosa E, Oertel WH, Giese A, Roeber S, Arzberger T, Wagenpfeil S, Hoglinger GU, Movement Disorder Society-endorsed PSPSG (2014) The phenotypic spectrum of progressive supranuclear palsy: a retrospective multicenter study of 100 definite cases. Mov Disord 29:1758–1766

    Article  PubMed  Google Scholar 

  35. Scotton WJ, Shand C, Todd E, Bocchetta M, Cash DM, VandeVrede L, Heuer H, Young AL, Oxtoby N, Alexander DC, Rowe JB, Morris HR, Boxer AL, Rohrer JD, Wijeratne PA, Prospect Consortium RC (2023) Uncovering spatiotemporal patterns of atrophy in progressive supranuclear palsy using unsupervised machine learning. Brain Commun 5:fcad048

    Article  PubMed  PubMed Central  Google Scholar 

  36. Seniaray N, Verma R, Ranjan R, Belho E, Mahajan H (2022) (18)F-FDG PET/CT and 99mTc-TRODAT scan findings in the variants of progressive supranuclear palsy and correlation with clinical findings. Ann Indian Acad Neurol 25:880–889

    Article  PubMed  PubMed Central  Google Scholar 

  37. Shir D, Pham NTT, Botha H, Koga S, Kouri N, Ali F, Knopman DS, Petersen RC, Boeve BF, Kremers WK, Nguyen AT, Murray ME, Reichard RR, Dickson DW, Graff-Radford N, Josephs KA, Whitwell J, Graff-Radford J (2023) Clinicoradiologic and neuropathologic evaluation of corticobasal syndrome. Neurology 101:e289–e299

    Article  CAS  PubMed  Google Scholar 

  38. Srulijes K, Reimold M, Liscic RM, Bauer S, Dietzel E, Liepelt-Scarfone I, Berg D, Maetzler W (2012) Fluorodeoxyglucose positron emission tomography in Richardson’s syndrome and progressive supranuclear palsy-parkinsonism. Mov Disord 27:151–155

    Article  PubMed  Google Scholar 

  39. Steele JC, Richardson JC, Olszewski J (1964) Progressive supranuclear palsy. a heterogeneous degeneration involving the brain stem, basal ganglia and cerebellum with vertical gaze and pseudobulbar palsy, Nuchal dystonia and dementia. Arch Neurol 10:333–359

    Article  CAS  PubMed  Google Scholar 

  40. Tsuboi Y, Josephs KA, Boeve BF, Litvan I, Caselli RJ, Caviness JN, Uitti RJ, Bott AD, Dickson DW (2005) Increased tau burden in the cortices of progressive supranuclear palsy presenting with corticobasal syndrome. Mov Disord 20:982–988

    Article  PubMed  Google Scholar 

  41. Whitwell JL, Duffy JR, Strand EA, Xia R, Mandrekar J, Machulda MM, Senjem ML, Lowe VJ, Jack CR Jr, Josephs KA (2013) Distinct regional anatomic and functional correlates of neurodegenerative apraxia of speech and aphasia: an MRI and FDG-PET study. Brain Lang 125:245–252

    Article  PubMed  PubMed Central  Google Scholar 

  42. Whitwell JL, Hoglinger GU, Antonini A, Bordelon Y, Boxer AL, Colosimo C, van Eimeren T, Golbe LI, Kassubek J, Kurz C, Litvan I, Pantelyat A, Rabinovici G, Respondek G, Rominger A, Rowe JB, Stamelou M, Josephs KA, Movement Disorder Society-endorsed PSPSG (2017) Radiological biomarkers for diagnosis in PSP: where are we and where do we need to be? Mov Disord 32:955–971

    Article  PubMed  PubMed Central  Google Scholar 

  43. Whitwell JL, Master AV, Avula R, Kantarci K, Eggers SD, Edmonson HA, Jack CR Jr, Josephs KA (2011) Clinical correlates of white matter tract degeneration in progressive supranuclear palsy. Arch Neurol 68:753–760

    Article  PubMed  PubMed Central  Google Scholar 

  44. Whitwell JL, Stevens CA, Duffy JR, Clark HM, Machulda MM, Strand EA, Martin PR, Utianski RL, Botha H, Spychalla AJ, Senjem ML, Schwarz CG, Jack CR Jr, Ali F, Hassan A, Josephs KA (2019) An evaluation of the progressive supranuclear palsy speech/language variant. Mov Disord Clin Pract 6:452–461

    Article  PubMed  PubMed Central  Google Scholar 

  45. Whitwell JL, Tosakulwong N, Botha H, Ali F, Clark HM, Duffy JR, Utianski RL, Stevens CA, Weigand SD, Schwarz CG, Senjem ML, Jack CR, Lowe VJ, Ahlskog JE, Dickson DW, Josephs KA (2020) Brain volume and flortaucipir analysis of progressive supranuclear palsy clinical variants. Neuroimage Clin 25:102152

    Article  PubMed  Google Scholar 

  46. Whitwell JL, Xu J, Mandrekar J, Boeve BF, Knopman DS, Parisi JE, Senjem ML, Dickson DW, Petersen RC, Rademakers R, Jack CR Jr, Josephs KA (2013) Frontal asymmetry in behavioral variant frontotemporal dementia: clinicoimaging and pathogenetic correlates. Neurobiol Aging 34:636–639

    Article  PubMed  Google Scholar 

  47. Williams DR, de Silva R, Paviour DC, Pittman A, Watt HC, Kilford L, Holton JL, Revesz T, Lees AJ (2005) Characteristics of two distinct clinical phenotypes in pathologically proven progressive supranuclear palsy: Richardson’s syndrome and PSP-parkinsonism. Brain 128:1247–1258

    Article  PubMed  Google Scholar 

  48. Williams DR, Holton JL, Strand K, Revesz T, Lees AJ (2007) Pure akinesia with gait freezing: a third clinical phenotype of progressive supranuclear palsy. Mov Disord 22:2235–2241

    Article  PubMed  Google Scholar 

  49. Zhao P, Zhang B, Gao S (2012) 18F-FDG PET study on the idiopathic Parkinson’s disease from several parkinsonian-plus syndromes. Parkinsonism Relat Disord 18(Suppl 1):S60-62

    Article  PubMed  Google Scholar 

Download references

Acknowledgements

The authors would like to acknowledge Dr. Dennis Dickson, Mayo Clinic, for performing the autopsy evaluations. This study was funded by the National Institutes of Health Grants R01-NS89757, R01-DC12519 and R01-DC14942.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Jennifer L. Whitwell.

Ethics declarations

Conflicts of interest

The authors have no competing interests.

Ethical approval

This study was approved by the Mayo Clinic IRB with informed consent obtained from all patients.

Rights and permissions

Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Black, J.A., Pham, N.T.T., Ali, F. et al. Frontal hypometabolism in the diagnosis of progressive supranuclear palsy clinical variants. J Neurol (2024). https://doi.org/10.1007/s00415-024-12350-z

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • DOI: https://doi.org/10.1007/s00415-024-12350-z

Keywords

Navigation